SLP - Simulations Plus, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Simulations Plus, Inc.

42505 Tenth Street West
Lancaster, CA 93534
United States
661-723-7723
http://www.simulations-plus.com

SectorTechnology
IndustryBusiness Software & Services
Full Time Employees83

Key Executives

NameTitlePayExercisedAge
Mr. Walter S. Woltosz M.S., M.A.S.Co-Founder, Chairman and Chief Exec. Officer223.2kN/A72
Mr. John Anthony DiBella M.S.Pres239.85kN/A37
Mrs. Virginia E. Woltosz M.B.A.Co-Founder, Treasurer and Sec.N/AN/A66
Mr. John R. Kneisel CPAChief Financial Officer187.94kN/A59
Dr. Thaddeus Henry Grasela Jr., PharmD, Ph.D.Director285kN/A63
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. The company distributes its products and services worldwide. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.

Corporate Governance

Simulations Plus, Inc.’s ISS Governance QualityScore as of December 1, 2017 is 6. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.